CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureylene

BMC Dermatology

Volumn 3, Issue , 2003, Pages

  Elias, Alan N ^a   Nanda, Vandana S ^b   Barr, Ronald J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CD1 ANTIGEN; INTERLEUKIN 12; PROPYLTHIOURACIL; THIOUREA DERIVATIVE; T6 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS PARAMETERS; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG RESPONSE; FEMALE; GRAVES DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LANGERHANS CELL; MACROPHAGE; MALE; MONOCYTE; PSORIASIS; SCORING SYSTEM; SKIN BIOPSY; BIOPSY; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; ANTIGENS, CD1; ANTITHYROID AGENTS; BIOPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPYLTHIOURACIL; PSORIASIS;

EID: 2442715161     PISSN: 14715945     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-5945-3-3     Document Type: Article

References (40)

1. Linden KG and Weinstein GD: current perspectives with an emphasis on treatment Am J Med 1999, 107:595-605.
2. Greaves MW and Weinstein GD: Treatment of psoriasis N Engl J Med 1995, 332:581-8.
3. Javitz HS, Ward MM, Farber E, Nail L and Vallow SG: The direct cost of care for psoriasis and psoriatic arthritis in the United States J Am Acad Dermatol 2002, 46:850-60.
4. Elias AN and Barr RJ: Low-dose oral propylthiouracil in the treatment of plaque psoriasis Int J Dermatol 1995, 34:519-20.
5. Elias AN, Goodman MM and Rohan MK: Effect of propylthiouracil and methimazole on serum levels of interleukin-2 receptors in patients with psoriasis Int J Dermatol 1993, 32:537-40.
6. Elias AN, Goodman MM, Liem WH and Barr RJ: Propylthiouracil in psoriasis: results of an open trial J Am Acad Dermatol 1993, 29:78-81.
7. Elias AN, Goodman MM, Rohan MK, Alpern K and Barr RJ: Methimazole (2-mercapto 1-methyl imidazole) in psoriasis - results of an open trial Dermatology 1993, 187:26-9.
8. Kose K, Utas S, Yazici C, Akdas A and Kelestimur F: Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis Br J Dermatol 2001, 144:1121-6.
9. Aust G, Sittig D, Steinert M, Lamesch P and Lohmann T: Graves' disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes Clin Exp Immunol 2002, 127:479-85.
10. Gupta MK: Thyrotropin receptor antibodies: advances and importance of detection techniques in thyroid diseases Clin Biochem 1992, 25:193-9.
11. Kohn LD, Shimojo N, Kohno Y and Suzuki K: An animal model of Graves' disease: understanding the cause of autoimmune hyperthyroidism Rev Endocr Metab Disord 2000, 1:59-67.
12. Kohn LD, Kosugi S, Ban T, Saji M, Ikuyama S, Giuliani C, Hidaka A, Shimura H, Akamizu T and Tahara K et al.: Molecular basis for the autoreactivity against thyroid stimulating hormone receptor Int Rev Immunol 1992, 9:135-65.
13. Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G and Hara E: Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence Nature 2001, 409:1067-70.
14. Wilson R, McKillop JH, Chopra M and Thomson JA: The effect of antithyroid drugs on B and T cell activity in vitro Clin Endocrinol (Oxf) 1988, 28(4):389-97.
15. Elias AN, Barr RJ, Rohan MK and Dangaran K: Effect of orally administered antithyroid thioureylenes on PCNA and P53 expression in psoriatic lesions Int J Dermatol 1995, 34:280-3.
16. Nickoloff BJ: The immunologic and genetic basis of psoriasis Arch Dermatol 1999, 135:1104-10.
17. Hong K, Chu A, Ludviksson BR, Berg EL and Ehrhardt RO: IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder J Immunol 1999, 162:7480-91.
18. Cheng J, Tu Y, Li J, Huang C, Liu Z and Liu D: A study on the expression of interleukin (IL)-10 and IL-12 P35, P40 mRNA in the psoriatic lesions J Tongji Med Univ 2001, 21:86-8.
19. Friedmann PS: Disappearance of epidermal Langerhans cells during PUVA therapy Br J Dermatol 1981, 105:219-21.
20. Czernielewski J, Juhlin L, Shroot S and Brun P: Langerhans' cells in patients with psoriasis: effect of treatment with PUVA, PUVA bath, etretinate and anthralin Acta Derm Venereol 1985, 65:97-101.
21. Dawe RS, Wainwright NJ, Cameron H and Ferguson J: Narrowband (TL-01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment? Br J Dermatol 1998, 138:833-9.
22. de Rie MA: Interleukin 12 and psoriasis Dermatology 1999, 199:101.
23. Tamura M, Matsuura B, Miyauchi S and Onji M: Dendritic cells produce interleukin-12 in hyperthyroid mice Eur J Endocrinol 1999, 141:625-9.
24. Athanasas-Platsis S, Savage NW, Winning TA and Walsh LJ: Induction of the CD1a Langerhans cell marker on human monocytes Arch Oral Biol 1995, 40:157-60.
25. Jones JL, Berth-Jones J, Fletcher A and Hutchinson PE: Assessment of epidermal dendritic cell markers and T-lymphocytes in psoriasis J Pathol 1994, 174:77-82.
26. Dobmeyer JM, Dobmeyer TS and Schopf RE: Importance of HLA-DR+ and CD1a+ epidermal cells for cytokine production in psoriasis Adv Exp Med Biol 1995, 378:539-41.
27. Albertson DG, Fishpool R, Sherrington P, Nacheva E and Milstein C: Sensitive and high resolution in situ hybridization to human chromosomes using biotin labelled probes: assignment of the human thymocyte CD1 antigen genes to chromosome 1 EMBO J 1988, 7:2801-5.
28. Calabi F and Milstein C: A novel family of human major histocompatibility complex-related genes not mapping to chromosome 6 Nature 1986, 323:540-3.
29. Beckman EM, Melian A, Behar SM, Sieling PA, Chatterjee D, Furlong ST, Matsumoto R, Rosat JP, Modlin RL and Porcelli SA: CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family J Immunol 1996, 157:2795-803.
30. Fredriksson T and Pettersson U: Severe psoriasis - oral therapy with a new retinoid Dermatologica 1978, 157:238-44.
31. Asawanonda P, Anderson RR, Chang Y and Taylor CR: 308-nm excimer laser for the treatment of psoriasis: a dose-response study Arch Dermatol 2000, 136:619-24.
32. Larko O: Phototherapy of psoriasis - clinical aspects and risk evaluation Acta Derm Venereol Suppl (Stockh) 1982, 103:1-42.
33. Ebner S, Ratzinger G, Krosbacher B, Schmuth M, Weiss A, Reider D, Kroczek RA, Herold M, Heufler C, Fritsch P and Romani N: Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4 J Immunol 2001, 166:633-41.
34. Caux C, Dezutter-Dambuyant C, Schmitt D and Banchereau J: GMCSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells Nature 1992, 360:258-61.
35. Breathnach AS: Aspects of epidermal ultrastructure J Invest Dermatol 1975, 65:2-15.
36. Plath T, Detjen K, Welzel M, von Marschall Z, Murphy D, Schirner M, Wiedenmann B and Rosewicz S: A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptor J Cell Biol 2000, 150:1467-78.
37. Nestle FO and Nickoloff BJ: Dermal dendritic cells are important members of the skin immune system Adv Exp Med Biol 1995, 378:111-6.
38. Lenz A, Heine M, Schuler G and Romani N: Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization J Clin Invest 1993, 92:2587-96.
39. Czernielewski J, Vaigot P and Prunieras M: Epidermal Langerhans cells - a cycling cell population J Invest Dermatol 1985, 84:424-6.
40. Kanitakis J, Hoyo E, Perrin C and Schmitt D: Electron-microscopic observation of a human epidermal Langerhans cell in mitosis J Dermatol 1993, 20:35-9.